Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Sanofi (SNY) had Operating Margin of 7.98% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$14.10B |
|
$-879.33M |
|
$4.33B |
|
$9.77B |
|
$12.98B |
|
$1.13B |
|
$-2.13B |
|
$-1.01B |
|
$1.27B |
|
$-622.66M |
|
$-888.74M |
|
$-870.02M |
|
$2.04B |
|
$1.13B |
|
$1.13B |
|
2.44B |
|
2.45B |
|
$-0.36 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$35.02B |
|
$11.37B |
|
$108.45B |
|
$143.47B |
|
$32.07B |
|
$16.12B |
|
$30.26B |
|
$62.33B |
|
$81.13B |
|
$4.69B |
|
$81.13B |
|
2.44B |
|
| Cash Flow Statement Financials | |
$12.16B |
|
$-2.77B |
|
$-9.29B |
|
$8.42B |
|
$8.66B |
|
$244.38M |
|
-- |
|
$-5.44B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
0.17 |
|
0.26 |
|
69.26% |
|
|
Operating Margin |
7.98% |
7.98% |
|
-- |
|
-7.13% |
|
-6.24% |
|
$9.12B |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.38 |
|
1.42 |
|
63.60 |
|
-1.10% |
|
-18.93% |
|
-0.62% |
|
-0.91% |
|
$33.26 |
|
$3.72 |
|
$4.96 |
|